![](https://endpts.com/wp-content/uploads/2023/01/Vector-BioMed-CEO-Boro-Dropulić.jpg)
Boro Dropulić, Vector BioMed CEO
Vector BioMed launches with $15M to produce backlogged CAR-T component
The manufacture of lentiviral vectors has been grabbing the attention of investors both small and large as of late, and another manufacturer is looking to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.